Malina (Desogestrel)

Desogestrel binds to progesterone receptors in the hypothalamus and pituitary, suppressing the luteinizing hormone surge and thereby inhibiting ovulation. It also creates a cervical mucus environment that is hostile to sperm and modifies the uterine lining to make implantation unlikely.

The prescribed dose of Malina is determined by a qualified healthcare professional. Typically, the regimen involves taking one tablet daily at the same time each day, but the exact schedule should follow the prescriber’s instructions.

Malina is contraindicated in pregnancy (Category X) and should not be started in pregnant women. While limited data exist for breastfeeding, the product is generally not recommended unless the benefits outweigh potential risks, and a clinician should evaluate each case.

To order Malina, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike combined oral contraceptives that contain estrogen and progestin, Malina contains only desogestrel, eliminating estrogen‑related risks such as thromboembolism in certain populations. It is suitable for women who cannot tolerate estrogen, but may have a slightly higher rate of breakthrough bleeding compared with combined pills.

Malina tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container. Protect them from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf life.

Malina is taken orally as a tablet. Swallow the tablet whole with water, preferably at the same time each day. No food restrictions are required, but consistent daily intake helps maintain contraceptive effectiveness.

The most serious risks include venous thromboembolism (deep‑vein thrombosis or pulmonary embolism), severe hypertension, and rare hepatic tumors. Patients should seek immediate medical attention if they experience unexplained leg pain, shortness of breath, severe headache, or visual changes.

Malina should not be used by women who are pregnant, have active thromboembolic disease, severe liver impairment, known hypersensitivity to desogestrel, or who smoke cigarettes and are over 35 years old. Consultation with a healthcare provider is essential before starting therapy.